Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2020, Bridgewest Ventures is a deep tech incubator based in New Zealand and serves as the innovation engine of the Bridgewest Group. The firm focuses on pre-seed to Series C funding stages and targets global and Oceania markets. It aims to support ventures that can create a positive global impact through innovative technologies.
Bridgewest Ventures invests in deep tech sectors, including clean technology, artificial intelligence and machine learning (AI/ML), medical technology (medtech), life sciences, and advanced sensors. The firm is selective in its partnerships, seeking to leverage its global track record and technical expertise to accelerate growth and mitigate risks for its portfolio companies.
Notable portfolio companies include BioOra, which automates the manufacturing of personalized cell therapies for cancer treatments; MACSO, which pioneers advanced sensory AI integration for animal welfare in agri-tech; and Precision Chroma, which develops 3D printed monolith adsorption columns for the purification of biological therapeutics.
Submit your pitch through their website's contact form for consideration.
Yes, Bridgewest Ventures often leads funding rounds, particularly in the pre-seed and seed stages, where they can provide significant support and resources.
The firm is open to follow-on investments, especially for companies that demonstrate strong growth potential and alignment with their deep tech focus.
Specific fund size details are not publicly disclosed, but the firm actively invests across various stages from pre-seed to Series C.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.